Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.63 -0.01 (-2.02%)
As of: Sep 30, 2026 · 3:47 PM EDT

Biodexa Pharmaceuticals (BDRX) Asset Utilization Ratio (2018)

Updated

Biodexa Pharmaceuticals' Asset Utilization Ratio was 0.05 in the year ended Dec 31, 2023, down 32.4% from 0.07 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Asset Utilization Ratio (2018) Analysis & Trends

From the year ended Dec 31, 2014 onward, Biodexa Pharmaceuticals has reported Asset Utilization Ratio for 10 years.

  • The figure for the year ended Dec 31, 2023 marks the lowest annual Asset Utilization Ratio since the year ended Dec 31, 2020.
  • Per Business Quant data, Asset Utilization Ratio in earlier years was 0.07 in the year ended Dec 31, 2022 (+34.3%), 0.05 in the year ended Dec 31, 2021 (+209.4%), 0.02 in the year ended Dec 31, 2020 (-34.4%) and 0.03 in the year ended Dec 31, 2019 (-54.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.49
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.47
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.52
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.44
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.53
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 0.47
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 0.77
API Access

Biodexa Pharmaceuticals Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BDRX&period=max&api_key=YOUR_API_KEY